CV-SQuISH-ED: Clinical Validation Study

UnknownOBSERVATIONAL
Enrollment

599

Participants

Timeline

Start Date

May 18, 2021

Primary Completion Date

January 13, 2022

Study Completion Date

May 1, 2022

Conditions
SepsisInfection
Interventions
DIAGNOSTIC_TEST

Cytovale IntellipSep test

The Cytovale IntelliSep test measures a series of physical properties that indicate activation of leukocytes obtained from a venous K2-EDTA anti-coagulated whole blood sample.

Trial Locations (4)

27157

Wake Forest Baptist Health, Winston-Salem

65212

University of Missouri, Columbia

70808

Lady of the Lake Regional Medical Center, Baton Rouge

98104

University of Washington, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cytovale, Inc.

INDUSTRY